/
GMED
$78.07-$5.87 (-6.99%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$11.7B
136M shares
52-week range
$51.79 – $101.40
53% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.52
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $713.0M | $785.4M | $789.0M | $958.1M | $1.02B | $1.57B | $2.52B | $2.94B |
| Cost of revenue | $159.4M | $180.0M | $217.5M | $239.2M | $263.7M | $548.2M | $1.04B | $957.8M |
| Gross profit | $553.6M | $605.4M | $571.6M | $718.9M | $759.1M | $1.02B | $1.48B | $1.98B |
| Gross margin | 77.6% | 77.1% | 72.4% | 75.0% | 74.2% | 65.1% | 58.9% | 67.4% |
| R&D | $55.5M | $60.1M | $84.5M | $97.3M | $73.0M | $124.0M | $163.8M | $185.0M |
| Operating income | $169.3M | $172.0M | $111.4M | $172.0M | $228.0M | $133.1M | $166.0M | $479.8M |
| EBITDA | $218.5M | $229.5M | $178.3M | $264.7M | $304.5M | $346.6M | $473.7M | $729.9M |
| Net income | $156.5M | $155.2M | $102.3M | $149.2M | $190.2M | $122.9M | $103.0M | $537.9M |
| Net margin | 21.9% | 19.8% | 13.0% | 15.6% | 18.6% | 7.8% | 4.1% | 18.3% |
| EPS (diluted) | 1.54 | 1.52 | 1.01 | 1.44 | 1.85 | 1.07 | 0.75 | 3.92 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3.2B | $4.74 | $4.72–$4.75 | 8 |
| 2027 | $3.4B | $5.15 | $4.84–$5.40 | 8 |
| 2028 | $3.6B | $5.69 | $5.47–$6.01 | 5 |
| 2029 | $4.0B | $6.59 | $6.51–$6.67 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$40.52
Price
$78.07
Implied downside
-48%
Peer comparison
GLOBUS MEDICAL INC
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
www.globusmedical.com- Employees
- 6,000
- IPO / List date
- Aug 3, 2012
- HQ
- AUDUBON, PA
Held by traders on TradeandTell
No one on the platform currently holds GMED.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 330,463 | $28.5M |
| Renaissance Technologiesas of 2025-09-30 | 243,918 | $14.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GMED yet.
